Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

Will The United States Ever Catch Up To Canada?

Jun 14, 2017 • 10:51 AM EDT
4 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

While the Canadian cannabis industry continues to evolve and expand, the United States cannabis industry continues to be attacked by members of Trump’s administration.

For this reason, the massive inflow of capital in the Canadian cannabis industry makes perfect sense. Companies levered to this opportunity have taken advantage of the capital pouring in and have been executing quickly to build on their lead over the US and countries with legal cannabis programs (i.e. Australia, Germany, and Colombia).

The Canadian cannabis sector has come well off its 2017 highs and we think this pullback has created a great opportunity for the following companies:

  • Canopy Growth (WEED.TO) (TWMJF) which has cannabis operations in Canada, Germany and Australia, and is well positioned to take advantage of a burgeoning global opportunity. Canopy Growth has the largest market share of the Canadian cannabis industry and it has the capital to continue to grow through organic and inorganic initiatives. 
  • Aurora Cannabis (ACB.V) (ACBFF) also has a global presence and the company has made several strategic partnerships, investments, and acquisitions so far this year. Aurora has one of the strongest balance sheets and it is currently working on the building of a massive new facility.
  • Emblem Cannabis (EMC.V) (EMMBF) is very different from its peers and is also focused on the biotech side of the cannabis industry. Emblem is led by a top-notch management team that is focused on creating value for shareholders through the sale of medical and recreational cannabis and by developing pharmaceutical products derived from cannabis.

An Industry that Continues to Execute

The Canadian cannabis industry continues to progress rapidly ahead of the country’s plan to legalize recreational cannabis in 2018 and we want to highlight three company developments reported earlier this week.

Yesterday, WeedMD Inc. (WMD.V) edged higher after the company announced that it will begin selling cannabis clones to patients registered for home grow under the ACMPR. WeedMD will initially offer several strains and plans to increase the number of strains offered based on customer feedback.

After reporting an important development last week, Tetra Bio-Pharma (TBP.CN) (TBPMF) and The New Brunswick Health Research Foundation announced that it would be investing a combined $1 million over five years to establish a Health Research Chair in Cannabis at the University of New Brunswick (UNB). The chair will focus on the study of biochemistry, medicinal use and pharmacology of cannabis. This research will expand UNB’s commitment to research and innovation in the field of natural product and biomedical, health and life sciences – adding to its reputation as a leader in natural products’ research.

Health Canada continues to work through new and existing ACMPR applications and yesterday, Cannabis Wheaton (CBW.V) (KWFLF) announced that its partner, Sundial Growers was granted a cultivation license under the ACMPR for its facility located near Airdrie, Alberta. Sundial is the company’s seventh licensed producer partner and has 1 of 3 licenses in Alberta, which is now the third province to have a Cannabis Wheaton partner with a license. Cannabis Wheaton’s interim streaming agreement with Sundial contemplates an aggregate contribution of up to $29 million to fund the construction of Sundial’s facility.  


Become a Mushroomstocks Premium Member to learn more!

Important Investor Disclosures 

Disclosure.  Compensated Affiliate. This content was authored by and is property of Mushroomstocks.  All information and data relied upon in drafting this report is publicly available.  The author believes and considers its sources to be reliable, but does not guarantee the accuracy or completeness of any information contained in this report.  Any and all information, data, analyses and opinions are provided for informational purposes only and is not intended, in any manner, as investment advice.  Any projections or other information generated by Mushroomstocks regarding the likelihood of various investment outcomes are hypothetical in nature, do not reflect actual investment results, and are not guarantees of future results.  None of the material contained in this report is intended as a solution or offer to sell or purchase a specific stock or any other investment.  This report is not directed to, or intended for distribution or use by, any person or entity that is a citizen, resident or located in any municipality, state, country or other jurisdiction where the distribution, publication, availability, or use of this report is contrary to any governing law or regulation.  The securities discussed in this report may not be eligible for purchase and/or sale in certain jurisdictions or by particular individuals.  It is important that you check any and all governing laws and/or regulations that may be applicable in your jurisdiction.  Investing in securities of issuers organized outside of the United States, including ADRs, entail certain risks.  The securities of non-United States issuers may not be registered with, nor be subject to the reporting requirements of the United States Securities and Exchange Commission.  Please contact a Financial Advisor for professional advice regarding any and all securities investments.  This report is intended for informational purposes only StoneBridge Partners’s officers, directors, employees, affiliates, or subsidiaries may have positions in securities covered by StoneBridge Partners.  StoneBridge Partners may receive compensation from the company and/or has a position in the securities mentioned in this report.

Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.